Live symbol workspace

XLV market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $146.81

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$139.47

Resistance

$154.15

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$146.81

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for XLV skewed bullish (7 of 14 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▼ 8.8 pts vs previous week

Avg confidence across 28 calls in the last 7 days

What sources say

Bullish 7 articles

3 Healthcare Stocks with Open Questions

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

Neutral 5 articles

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

Bearish 2 articles

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

XLV News Intelligence (32 articles)

AI-curated news influencing XLV price, sentiment, and trend

Explore All XLV News with AI Analysis

Economy

2 weeks, 6 days ago

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

IHE's pharma-focused portfolio delivered higher returns over the past year, while XLV offers a broader healthcare focus with a much …

Impact on XLV: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

3 weeks, 1 day ago

Time To Take Profits In XLV?

The healthcare fund just printed a record high, but cashing out of a steady compounder is often the wrong move.

Impact on XLV: Potentially positive price action expected

Financial market analysis indicating bullish sentiment based on current trends. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

3 weeks, 1 day ago

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

FBT delivered 48.5% returns over one year but carries a 0.55% expense ratio and experiences greater volatility. XLV offers lower …

Impact on XLV: May pressure downward momentum

Analysis of stock market developments showing bearish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

3 weeks, 1 day ago

1 Healthcare Stock to Keep an Eye On and 2 We Avoid

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the …

Impact on XLV: The outperformance of healthcare stocks may lead to continued sector rotation, with …

Healthcare stocks have outperformed the S&P 500 over the past six months, with a 14.3% … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 weeks, 2 days ago

JPMorgan says this S&P 500 sector "offers a rare combination of durable growth"

Investing.com -- JPMorgan reiterated a favorable view on the healthcare sector in a note Tuesday, calling the risk/reward attractive after …

Impact on XLV: The JPMorgan note may lead to a positive price reflection in healthcare …

JPMorgan has reiterated its favorable view on the S&P 500 healthcare sector, citing an attractive … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 weeks, 3 days ago

Hedge Fund Healthcare Bets Approach Five-Year High

Specialist funds returned nearly 40% as AI drug discovery and deal activity attracted additional capital.

Impact on XLV: The increased investment in healthcare is expected to positively impact healthcare stocks, …

Hedge fund investments in the healthcare sector have reached a nearly five-year high, driven by … High (80%)

View full analysis →

Yahoo Finance 80% confidence